GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

ViiV Healthcare will present new data from its long-acting and [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

FundaMental Pharma GmbH will present new preclinical data on its [...]

Oncoinvent will present final 24-month follow-up data from its Phase [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

Newron Pharmaceuticals has secured up to EUR 38 million in [...]

Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]